Hyperinsulinism-Causing Mutations Cause Multiple Molecular Defects

Subscriber access provided by HACETTEPE UNIVERSITESI KUTUPHANESI

Article

Hyperinsulinism-causing mutations cause multiple molecular defects in SUR1 NBD1 Claudia Paola Alvarez, Marijana Stagljar, D. Ranjith Muhandiram, and Voula Kanelis Biochemistry, Just Accepted Manuscript • DOI: 10.1021/acs.biochem.6b00681 • Publication Date (Web): 27 Mar 2017 Downloaded from http://pubs.acs.org on March 30, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Biochemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Hyperinsulinism-causing mutations cause multiple molecular defects in SUR1 NBD1 Claudia P. Alvarez1,2, Marijana Stagljar1,2,3, D. Ranjith Muhandiram4and Voula Kanelis1,2,3,* 1

Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359

Mississauga Road, Mississauga, Ontario, Canada L5L 1C6 2

Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario,

Canada M5S 3H6 3

Department of Cell and Systems Biology, University of Toronto, 25 Harbord Street, Toronto,

Ontario, Canada M5S 3G5 4

Department of Molecular Genetics, University of Toronto, 1 King's College Circle

Toronto, ON, CAN M5S 1A8

Corresponding Author *Voula Kanelis, DV 4042 Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road N., Mississauga, Ontario L5L 1C6; Tel: 1-905-569-4542; Fax: 1-905-828-5425; Email: [email protected]

ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Abbreviations SUR1, sulfonylurea receptor 1; KATP channels, ATP sensitive potassium channels; NBDs, nucleotide binding domains; NBD1, nucleotide binding domain 1; NBD2, nucleotide binding domain 2; SUR2, sulfonylurea receptor 2; MSD, membrane spanning domain; ATP, adenosine triphosphate; ABC protein, proteins from the ATP binding cassette superfamily; ADP, adenosine diphosphate; NMR, nuclear magnetic resonance; SUMO, small ubiquitin-like modifier; IPTG, isopropyl β-D-1-thiogalactopyranoside; Tris-HCl, Tris(hydroxymethyl)aminomethane hydrochloride; PMSF, phenylmethanesulfonyl fluoride; Ulp1, Ubiquitin-like-specific protease 1; DTT, dithiothreitol; TROSY, transverse relaxation optimized spectroscopy; HSQC, heteronuclear single quantum coherence; DSS, 4,4-dimethyl-4-silapetene-1-sulfonic acid; EDTA, ethylenediaminetetraacetic acid; KSV, Stern-Volmer quenching constant; MANT-ATP, 2'-(or-3')-O-(N-methylanthraniloyl) adenosine 5 triphosphate; NBD1-WT, wild type NBD1; NBD1-G716V, NBD1 with the G716V mutation; NBD1-R842G, NBD1 with the R842G mutation; NBD1-H863T, NBD1 with the H863T mutation; NBD1-K890T, NBD1 with the K890T mutation; τc, correlation time; S2, order parameter; Tm, melting temperature; CFTR, cystic fibrosis transmembrane conductance regulator; FRET, fluorescence resonance energy transfer; Kd, dissociation constant; TAP1, antigen peptide transporter 1; MRP1, multidrug resistance protein 1; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis

2 ACS Paragon Plus Environment

Page 2 of 45

Page 3 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Abstract The sulfonylurea receptor 1 (SUR1) protein forms the regulatory subunit in ATP sensitive K+ (KATP) channels in the pancreas. SUR proteins are members of the ATP-binding cassette (ABC) superfamily of proteins. Binding and hydrolysis of MgATP at the SUR nucleotide binding domains (NBDs) lead to channel opening. Pancreatic KATP channels play an important role in insulin secretion. SUR1 mutations that result in increased channel opening ultimately inhibit insulin secretion and lead to neonatal diabetes. In contrast, SUR1 mutations that disrupt trafficking and/or decrease gating of KATP channels cause congenital hyperinsulinism, where over secretion of insulin occurs even in the presence of low glucose. Here, we present data on the effects of specific congenital hyperinsulinism-causing mutations (G716V, R842G, and K890T) located in different regions of the first nucleotide binding domain (NBD1). Nuclear magnetic resonance (NMR) and fluorescence data indicate that the K890T mutation affects residues throughout NBD1, including residues that bind MgATP, NBD2, and coupling helices. The mutations also decrease the MgATP binding affinity of NBD1. Size exclusion and NMR data indicate that the G716V and R842G mutations cause aggregation of the NBD1 in vitro, possibly due to destabilization of the domain. These data describe structural characterization of SUR1 NBD1 and shed light on the underlying molecular basis of mutations that cause congenital hyperinsulinism.


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Introduction ATP sensitive K+ channels (KATP channels) are K+ selective channels that link the cell’s metabolism and membrane potential. KATP channels are hetero-octameric protein complexes comprised of four copies of a pore-forming inward-rectifying K+ channel (Kir6.1 or Kir6.2) and four copies of a sulfonylurea receptor (SUR1 or isoforms of SUR2) that surround the pore.1-7 SUR proteins are members of the ATP binding cassette (ABC) family of proteins8 and, as such, contain the minimum ABC protein architecture of two membrane-spanning domains (MSD1 and MSD2) and two nucleotide binding domains (NBD1 and NBD2). The transmembrane segments in the MSDs extend into the cytoplasm.9-23 Short helices, known as coupling helices,13 link the cytoplasmic extensions of the transmembrane helices and contact the NBDs. Thus, the coupling helices link conformational changes that occur at the NBDs to the rest of the SUR protein. Binding and hydrolysis of MgATP lead to altered interactions between NBD1 and NBD2, and associated conformational changes in the NBDs.24 SUR proteins contain an additional membrane-spanning domain (MSD0) that is linked to the minimum ABC structure by the cytoplasmic L0 linker.25-28 As with other members of the C subfamily of ABC proteins (ABCC) that includes the cystic fibrosis transmembrane conductance regulator (CFTR) and the multidrug resistant proteins 1 and 2 (MRP1 and MRP2), the SUR proteins contain asymmetric nucleotide binding sites.29 The NBD1 composite site, which is formed by the Walker A and Walker B motifs of NBD1 and the signature sequence of NBD2, contains a substitution of the catalytic Glu of the Walker B motif to an Asp. The substitution renders the NBD1 composite site catalytically inactive, and thus the NBD1 composite site is referred to as the degenerate ATP binding site. In contrast, the motifs that form the NBD2 composite site bear consensus sequences. Thus the NBD2 composite site, which is capable of MgATP binding and hydrolysis, is termed the consensus site. Unlike most members of the ABC protein family, the SUR proteins do not possess any transport activity but instead regulate gating of the KATP channel pore.1, 2, 4, 30-35 ATP binding at the Kir6.x pore results in KATP channel inhibition. Data on full-length channels containing SUR2A and SUR2B indicate that KATP channels open in response to MgADP binding at NBD2, which requires MgATP binding at NBD1.30, 35 The interaction of NBD2 with MgADP may result from direct nucleotide binding or hydrolysis of MgATP to MgADP at NBD2.30, 34, 35 The


Page 4 of 45

Page 5 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

similarity of SUR1 and SUR2 proteins suggests that a similar mechanism functions in activation of SUR1-containing KATP channels. KATP channels in the pancreatic β-cells, which are composed of Kir6.2 and SUR1 proteins, regulate insulin secretion.1, 2, 36-39 Under conditions of high glucose, the ATP:ADP ratio in the cell is high and KATP channels are closed. The closure of KATP channels depolarizes the plasma membrane, which in turn opens voltage-gated Ca2+ channels, resulting in increased intracellular Ca2+concentration and subsequent insulin secretion. When the ATP:ADP ratio is low, the KATP channels are open and the plasma membrane is hyperpolarized. Hyperpolarization of the membrane keeps the voltage-gated Ca2+ channels closed, preventing insulin release. Mutations in SUR1 that disrupt the ability of KATP channels to close under high glucose concentrations cause neonatal diabetes.37, 39-41 Conversely, mutations that decrease KATP channel opening result in congenital hyperinsulinism,37, 39-43 which is characterized by constant insulin secretion, despite low glucose concentration.44 Congenital hyperinsulinism usually presents within the first few days after birth. Treatment of congenital hyperinsulinism, either with the drug diazoxide that promotes KATP channel opening or with partial or near-total pancreatectomy, is necessary to prevent brain damage from the associated hypoglycemia.45, 46 Mutations that cause congenital hyperinsulinism affect many parts of the SUR1 protein, including the NBDs,40, 41, 45 and cause a decreased response of the channel to MgADP and/or reduce the expression of the number of KATP channels at the plasma membrane.37, 47-53 These mutations can elicit their effects on KATP channel gating and trafficking by a number of molecular mechanisms. For example, NBD mutations that affect MgADP activation may reduce the nucleotide binding affnity of the domain, compromise NBD dimerization, or alter NBD/coupling helix interactions. Compromised interactions between NBD1 and NBD2, and betweeen the NBDs and coupling helices would also affect folding and assembly of the KATP channel, and thus trafficking of the channel to the plasma membrane. Mutations may also alter the structure and/or destabilize the indvidual NBDs, which would compromise the interactions necessary for KATP channel assembly and trafficking. An understanding of the molecular defects imparted by different mutations is essential for developing specific therapies, as has been done for diseases of other ABC proteins.54, 55 During revision of this manuscript, high-resolution structures of a pancreatic KATP channel in the closed state were published.56, 57 The KATP channel adopts a propeller structure, 5 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

with the centre of the propeller formed by the Kir6.2 proteins and the MSD0 of SUR1, and the blades of the propeller comprised of the minimum ABC structure of the SUR1 subunits. There are multiple interactions between the first transmembrane helix of SUR1 MSD0 and a Kir6.2 transmembrane helix.56, 57 Perturbation of these interactions may explain how hyperinsulinismcausing mutations in SUR1 MSD0 impair assembly and cell surface expression of pancreatic KATP channels.57, 58 Notably, there are no interactions between the minimum ABC structure (or ABC core) of adjacent SUR1 subunits or between the SUR1 ABC core and Kir6. Further, the SUR1 NBDs are not bound to Mg nucleotides, and thus the ABC core of SUR1 adopts an inward facing conformation in which the NBDs are separated from one another. Thus, additional structural information is needed to understand molecular basis underlying disease-causing mutations in the SUR1 NBDs. To this end, we present studies describing how several congenital hyperinsulinismcausing mutations (G716V, R842G, and K890T; Figure 1)39-41 affect the structure and activity of SUR1 NBD1. These data constitute the first structural studies of wild type and mutant forms of SUR1 NBD1. We have obtained resonance assignments for NBD1 and have probed conformational changes in NBD1 imparted by disease-causing mutations. NMR and fluorescence studies indicate that the K890T mutation affects many residues throughout NBD1, and results in decreased MgATP binding and thermodynamic stability of the domain. Data on NBD1 with the G716V and R842G mutations indicates that these two mutations cause aggregation of the NBD1 in vitro, possibly due to destabilization of the domain structure. Size exclusion chromatography and NMR spectroscopy suggest that changes to NBD1 structure by the K890T mutation are not as severe as those imparted by the G716V and R842G, consistent with the disease severity of the different mutations. Our data shed light on the underlying molecular basis by which specific SUR1 mutations cause congenital hyperinsulinism, and provide a platform to assess the effects of other mutations in SUR1.


Page 6 of 45

Page 7 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Figure 1. Ribbon diagram of a homology model of the SUR1 NBD1/NBD2 heterodimer. The NBD1 ribbon diagram is coloured in light blue, except for Walker A, Walker B, signature sequence and Q loop residues which are coloured in magenta, green, orange, and blue, respectively. The NBD2 ribbon is grey. The Cα atom of G716 and side chain atoms of R842 and K890 are shown in red spheres, whereas the side chains of Trp residues are shown as yellow sticks.

Experimental Procedures Protein expression. The human SUR1 NBD1 proteins (D671-L956) in the wild type state, bearing hyperinsulinism–causing mutations (G716V, R842G, and K890T) or the diabetescausing mutation H863T, and with mutations of specific Trp residues (W688F, W778F, W928F) were expressed with an N-terminal His6-SUMO tag59 using a modified pET26b-derived expression vector.60 We also generated samples of human SUR1 NBD1 lacking residues encoded by exon 17 (S742-S753) and residues Q937-L956, which are homologous to the disordered Cterminal tail in SUR2A (and SUR2B) NBD1,61, 62 that we refer to as NBD1-WT-∆17∆C. For wild type NBD1 (NBD1-WT), constructs were generated from the cDNA of isoform 1 (NCBI accession code: NP_001274103) and isoform 2 (NCBI accession code: NP_000343) of SUR1. Isoforms 1 and 2 of SUR1 differ only by the insertion of a Ser residue at position 742 in isoform 1. Because wild type NBD1 from isoform 2 is more soluble than NBD1 from isoform 1, we conducted all studies with NBD1 from isoform 2 of SUR1. However, we are using residue numbers of isoform 1 in this paper in order to be consistent with the residue numbering of SUR1 in the literature. The domain boundaries of D671-L956 chosen correspond to those used to obtain soluble samples of SUR2B NBD1.62 The His6-SUMO-NBD1 fusion proteins were expressed in Escherichia coli BL21 (DE3) CodonPlus®RIL cells (Stratagene) grown in M9 media that was supplemented with 5 % LB and contained 15NH4Cl to enable isotopic enrichment with 15N for NMR studies. Cells expressing the His6-SUMO-NBD1-WT-∆17∆C fusion protein for NMR resonance assignment experiments were grown in 97.5 % M9 minimal media (containing 15NH4Cl, 13C-glucose, and 70 % 2H2O) and 2.5 % 15N/13C-labeled E. coli-OD2 media (Silantes) to achieve uniform 15N/13C-labeling and 7 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

fractional 2H labeling. The cell cultures were incubated at 37 °C with constant agitation at 250 rpm until the OD600 reached 0.4 at which point the temperature was decreased gradually so that when the temperature was 18 °C the cell culture OD600 was 0.8. The cultures were then incubated at 18 ºC for 30 min, at which point protein expression was induced with 750 µM isopropyl β-D-thiogalactoside (IPTG). After ~18 hrs, the cells were harvested by centrifugation at 4 °C and cell pellets were stored at -20 °C until purification. Protein purification. The SUR1 NBD1 proteins were purified using the general protocol described previously for NBD1 from rat SUR2A and SUR2B,61-63 with a few modifications. All purification steps were conducted at 4 ºC. Cell pellets from 2 L of culture with final OD600 values of ~1.9 were resuspended in 50 mL of lysis buffer (20 mM Tris-HCl, pH 7.6, 10 % [v/v] glycerol, 150 mM NaCl, 10 mM imidazole, 100 mM arginine, 2 mM β-mercaptoethanol, 15 mM MgCl2, 15 mM ATP, 0.2 % [v/v] Triton X-100, 2 mg/mL deoxycholic acid, 1 mg/mL lyzozyme, 5 mM benzamidine, 5 mM ε-aminocaproic acid and 1 mM PMSF). The cells were lysed by sonication and the insoluble cellular debris was removed by centrifugation at 17000 g-1 for 30 min. The lysate was filtered through a 0.45 µm filter (Pall) and loaded onto a 5 mL Ni2+-NTA affinity column (GE Healthcare) that was pre-equilibrated with 20 mM Tris-HCl pH 7.6, 10 % (v/v) glycerol, 150 mM NaCl and 10 mM imidazole. The Ni2+-NTA affinity column was washed with 6 column volumes of wash buffer (20 mM Tri-HCl pH 7.6, 10 % [v/v] glycerol, 150 mM NaCl, 10 mM imidazole, 5 mM MgCl2 and 5 mM ATP) and the His6-SUMO-NBD1 protein was eluted in 20 mM Tris-HCl, pH 7.6, 10 % (v/v) glycerol, 150 mM NaCl, 400 mM imidazole, 15 mM MgCl2, 15 mM ATP, 2 mM β-mercaptoethanol, 1 mM benzamidine and 1 mM εaminocaproic acid. The elution fractions were immediately diluted 2-fold with a buffer containing 20 mM Tris-HCl pH 7.6, 10 % (v/v) glycerol, 2 mM β-mercaptoethanol, 15 mM MgCl2, 15 mM ATP, 1 mM benzamidine and 1 mM εaminocaproic. The His6-SUMO tag was removed from NBD1 with His6-Ulp1 protease. The resulting mixture containing the His6-SUMO tag and SUR1 NBD1 was applied to a Superdex 75 size exclusion column (GE Healthcare) in 20 mM Tris-HCl pH 7.6, 5 % (v/v) glycerol, 150 mM NaCl, 2 mM β-mercaptoethanol, 5 mM MgCl2, 5 mM ATP, 1 mM benzamidine and 1 mM ε-aminocaproic acid. SUR1 NBD1 was purified to homogeneity with a reverse Co2+ affinity column (HisPur Cobalt Resin,


Page 8 of 45

Page 9 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

ThermoFisher) in 20 mM Tris-HCl pH 7.6, 5 % (v/v) glycerol, 150 mM NaCl and 25 mM imidazole. NMR Spectroscopy. Purified SUR1 NBD1 proteins were dialyzed against the NBD1 NMR buffer (20 mM Na+ phosphate buffer, pH 7.2, 2 % [v/v] glycerol, 50 mM NaCl, 2 mM DTT, 5 mM MgCl2 and 5 mM ATP). 1H-15N TROSY-HSQC64 and 15N R1ρ relaxation experiments were acquired on a 600 MHz Varian Inova spectrometer equipped with a H(F)CN triple resonance cryoprobe and actively shielded z-gradients. 1H-15N TROSY-HSQC spectra of SUR1 NBD1 in the wild type state (NBD1-WT) and bearing disease-causing mutations (NBD1G716V, NBD1-R842G, NBD1-H863T, and NBD1-K890T) were recorded at 30 °C in the NBD1 NMR buffer. 1H-15N TROSY-HSQC spectra were processed using NMRPipe/NMRDraw65 and differences between wild type and mutant NBD1 spectra were analyzed using NMRView.66 Chemical shift were referenced to 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS).67 Chemical shift changes from the K890T mutation were determined by calculating the combined chemical shift difference in Hz, ∆δtot, from the equation ∆δtot = (∆δHN2 + ∆δN2)0.5.63, 68 When assessing chemical shift differences, only resonances exhibiting a significant combined chemical shift difference (∆δtot), which is greater than the average of all ∆δtot values plus one standard deviation are considered. For NMR data presented in this paper, only ∆δtot ≥ 8.5 Hz are considered. 15

N R1ρ relaxation experiments were recorded on at 30 °C using previously pulse

schemes.69, 70 15N R1ρ values were measured from six different spectra recorded with delays of 2, 6, 12, 28, 40 ms for a sample of 500 µM NBD1-WT. 15N R2values for each residue were obtained by correction of the observed relaxation rate R1ρ for the offset ∆ν of the applied spinlock rf field (ν1) to the resonance using the equation R1ρ = R2sin2θ, where θ = tan−1 (ν1/ ∆ν) and ν1 was 1865.7 Hz. All data sets were processed using NMRPipe. Peak intensities were obtained using the Rate Analysis tool in NMRView and used to fit a two parameter function of the form I(t) = I0e-t*R2 using a Matlab script.71 Errors in relaxation rates were estimated by Monte Carlo analysis. In total, 31 resolved peaks were analyzed. Backbone 1H, 15N, 13C, and 13Cα, and side chain 13Cβ resonance assignments for NBD1WT-∆17∆C were obtained from standard triple resonance TROSY-based experiments72, 73 recorded on samples of 0.5 mM NBD1-WT-∆17∆C that were uniformly 15N- and 13C-labeled and fractionally 2H labeled to ~50 %. The triple resonance assignment data were run on a 600


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

MHz spectrometer equipped with a HCN cryoprobe at 20 °C. These data were supplemented with 15N-1H TROSY HSQC spectra recorded on NBD1 samples that were either 15N-labeled only on specific amino acids (Leu, Val, Gly, or Gly and Ser)74-76 or 14N-labeled on Lys and 15Nlabeled at all other positions.77 We have obtained assignments for 88 % of backbone HN resonances of NBD1-WT-∆17∆C. The similarity of the NBD1-WT-∆17∆C and NBD1-WT spectra allowed for the straightforward transfer of resonance assignments for most residues. Resonance assignments of NBD1-WT-∆17∆C spectra at 20 °C were transferred to NBD1-WT∆17∆C spectra at 30 °C and subsequently to spectra of NBD1-WT at 30 °C. The combination of TROSY-based triple resonance data and specifically labeled samples has allowed for the level of resonance assignment obtained for other NBDs.62, 74 Assignments of Trp indole HN resonances were obtained by site-directed mutagenesis of NBD1. Thermal denaturation experiments. The thermal stabilities of wild type (NBD1-WT) and NBD1 with the K890T mutation (NBD1-K890T) were measured using intrinsic Trp fluorescence spectroscopy, as described previously.63 The NBD1 proteins were exchanged into the fluorescence buffer (20 mM Na+ phosphate, pH 7.2, 150 mM NaCl, 2 mM DTT, 2 % [v/v] glycerol) by size exclusion chromatography (Superdex 75). The higher NaCl concentration (of 150 mM) used for the fluorescence buffer compared to the NMR buffer (of 50 mM) is due to the fact that NaCl concentrations of 150 mM are necessary in the fluorescence buffer to prevent nonspecific binding of the protein to the chromatography resin. However, lower NaCl concentrations (of 50 mM) produce higher quality NMR spectra of SUR1 NBD1. In order to obtain MgATPbound NBD1 proteins, varying amounts of a freshly prepared MgATP solution was added to NBD1 samples immediately upon elution from the size exclusion column. Only NBD1 samples that eluted at a volume consistent with the monomeric protein were used. Fluorescence spectra were recorded with a Fluoromax-4 spectrofluorimeter (HORIBA) equipped with a Peltier unit for temperature control. NBD1 samples (2 µM, 0.5 mL) were heated from 10 ºC- 70 ºC in 1 ± 0.3 °C increments with a 1 min equilibration time at each temperature. The fluorescence intensity at each temperature was monitored at 345 nm, which is the wavelength at which the difference in the fluorescence intensity of the folded and denatured NBD1 is at a maximum. The excitation wavelength was 295 nm, and the excitation and emission slit widths were 2 nm and 4 nm, respectively. Fitting fluorescence thermal denaturation curves was not possible because of the steep slopes of the folded and unfolded baselines, likely due to the fact that there are five Trp 10 ACS Paragon Plus Environment

Page 10 of 45

Page 11 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

residues in SUR1 NBD1. Tm values were obtained by determining the midpoint of the transition of the melting curves graphically. A total of three experiments were performed and analyzed for each MgATP concentration tested. Fluorescence quenching experiments. Fluorescence quenching experiments were performed on 2 µM NBD1 samples in the presence and absence of 5 mM MgATP. As described above, NBD1-WT and NBD1-K890T samples were exchanged into fluorescence buffer lacking MgATP by size exclusion chromatography. MgATP was added to NBD1 samples that eluted at a volume consistent with monomeric protein to a final concentration of 5 mM, as required. Apo NBD1 samples contained 5 mM EDTA in place of the 5 mM MgATP, unless CsCl was used as the quencher, in which case no EDTA was added to the samples. Trp emission was recorded at 15 °C with an excitation wavelength of 295 nm, an excitation slit width of 2 nm, an emission wavelength of 345 nm, and an emission slit width of 4 nm. Acrylamide quenching experiments were performed by adding increasing amounts of a solution containing 1.6 M acrylamide in NBD1 fluorescence buffer. The absorbances at 295 nm (A295) and at 345 nm (A345) were recorded and the observed fluorescence was corrected for the inner filter effect, according to the equation Fcorrected = Fobserved

A295 +A345 78-80 10 2

.

The values of

A295 and A345 at the highest acrylamide concentration used were 0.080 and 0.005, respectively. To correct for the sample dilution upon addition of acrylamide, parallel titrations with buffer were performed. The normalized fluorescence (F) at each titration point was determined by dividing the Fcorrected by the fluorescence of NBD1 obtained from dilution of the sample (Fdilution), so that F =

equation81

Fcorrected . The normalized fluorescence data was analyzed using the Stern-Volmer Fdilution , where Fo is the fluorescence in absence of the quencher (Q)

acrylamide, to obtain the Stern-Volmer quenching constant, KSV. The KI and CsCl quenching experiments were performed by adding increasing amounts of a solution of 0.8 M KI or 0.8 M CsCl dissolved in the NBD1 fluorescence buffer. All quenching solutions were prepared fresh and 0.2 mM Na2S2O3 was added to the KI stock solution to prevent formation of I2 and I3- species.81 A separate titration with 0.8 M KCl was performed to account for NBD1 protein dilution and for the increase in ionic strength with 11 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 12 of 45

addition of I- or Cs+. The intial fluorescence (Fo) was divided by the fluorescence (F) at each point in the KI and in the KCl titrations to give (Fo/F)KI and (Fo/F)KCl, respectively.82 The net change in fluorescence was determined by the equation

and plotted against the

concentration of the quencher KI to obtain the Stern-Volmer constant (K ୱ୴ ). A similar analysis was used to calculate

F° (F° / F)CsCl = . F (F° / F) KCl

Nucleotide binding affinity. The nucleotide binding affinity of NBD1-WT and NBD1K890T was measured using the ATP analogue 2'-(or-3')-O-(N-methylanthraniloyl) adenosine 5O-triphosphate (MANT-ATP). The experiments were conducted at 15 °C with 0.05 µM or 0.25 µM for NBD1-WT and 0.25 µM for NBD1-K890T proteins that were freshly exchanged into the NBD1 fluorescence buffer containing 10 % (v/v) glycerol and 1 mM MgCl2 using size exclusion chromatography, which also ensured that monomeric NBD1 proteins were used. MANT-ATP titration experiments of NBD1-WT and NBD1-K890T were monitored at emission wavelengths of 345 nm and 440 nm with an emission slit width of 6 nm. The fluorescence excitation wavelength is 295 nm and the excitation slit width is 3 nm. The sample volume and protein concentration were kept constant throughout the titration, while the concentration of MANT-ATP was increased. The decreasing fluorescence at 345 nm with increasing concentration of MANT-ATP was due to quenching of the Trp residues in the protein upon binding of MANT-ATP and was fit according to the equation,83 assuming a 1:1 complex between NBD1 and MANT-ATP, F = Fo +

( F∞ − Fo )

([MANT − ATP l]+[NBD1 ]+ K )  tota total d   2[NBD1total ] −(([MANT − ATP ]+[NBD1 ]+ K ) 2 − 4[MANT − ATP ][NBD1 ])0.5  total total d total total

where F is the fluorescence at each point in the titration, Fo is fluorescence signal in the absence of MANT-ATP, F∞ is the fluorescence at a given total concentration of MANT-ATP, [MANT[ATPtotal], and [NBD1total] is the total NBD1 concentration in the sample. The increasing fluorescence at 440 nm is partly due to fluorescence resonance energy transfer between the Trp residues in NBD1 and the bound MANT-ATP, as the excitation wavelength of the MANT fluorophore overlaps with the emission wavelength of the Trp residues 12 ACS Paragon Plus Environment

Page 13 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

(345 nm). However, there are other mechanisms that contribute to the fluorescence at 440 nm that are not related to nucleotide binding, including direct excitation of free MANT-ATP molecules in solution by either the excitation light (at 295 nm) or emission of the Trp residues in unbound protein at 345 nm.84 In order to account for these additional mechanisms, we fit the increasing fluorescence data at 440 nm using the following equation derived by Kubala et al85

where γ corresponds to the enhancement of fluorescence of the bound MANT-ATP and is determined from the initial part of the curve, and Q is the signal increase due to excess free MANT-ATP in solution. Our method of extracting Kd values differs slightly from that of Kubala et al.85 First, Kubala et al divide the overall fluorescence intensity of samples containing protein and fluorescent ATP by Q (F/Q). Second, Kubala et al determine the value of γ with two additional titration experiments. The first experiment measures the signal for increasing concentrations of the fluorescence probe (e.g. MANT-ATP) in buffer (in absence of protein, so F = Q[MANT-ATPtotal]) while the second experiment monitors the fluorescence signal of increasing concentrations of the probe in the presence of enough excess protein so that all of the probe is bound (F = γQ[MANT-ATPtotal]). The ratio of the linear slopes obtained from these separate titrations is used to obtain the parameter γ. In our case, the Kd values for the interaction between MANT-ATP and NBD1-WT were small and as a result we were able to extract the parameters Q and γ directly from fitting the fluorescence at 440 nm. Because the values of A295, A345, and A440 at the highest MANT-ATP concentration used were very low (0.011, 0.009, and 0.001, respectively), which would affect the fluorescence emission intensity by only ≤ 2%, correction of fluorescence due to absorbance is not required. Decreasing and increasing fluorescence data were fit according to the equations above using Origin Pro.

Results Characterization of wild type human SUR1 NBD1. An understanding of the molecular defects imposed on NBD1 by disease-causing mutations first requires characterization of the wild type protein. Analytical size exclusion chromatography (Figure 2A,B) and NMR 13 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

spectroscopy (Figure 3,4) demonstrate that samples of wild type SUR1 NBD1 (NBD1-WT) are monomeric. NBD1-WT elutes at a volume of 10.12 mL (Figure 2A,B), which corresponds to a molecular mass of 44.3 kDa, and is similar to the elution volume observed for monomeric rat SUR2A NBD1.61 The earlier elution volume for wild type SUR1 NBD1 (and SUR2A NBD1) compared to that expected for a 32 kDa globular protein is due to disordered residues in the protein that increase the hydrodynamic radius of NBD1.86 Disordered residues include the last 20 C-terminal residues of the NBD1 construct and the loop connecting the β-sheet and α/β subdomains (discussed below).

Figure 2. The K890T mutation causes partial aggregation of NBD1. The size exclusion elution profiles of NBD1-WT (A,D) and NBD1-K890T (C,E,F) are shown. The elution volume of standards is indicated at the top of each plot. Note the difference in total column volumes (Vc) between profiles for panels A and C versus C, E, and F. Profiles for NBD1-WT and NBD1-K890T shown in panels D and E were obtained by adding 12.5 % (v/v) glycerol and 15 mM MgATP to the samples prior to loading them on the size exclusion column. The size exclusion profile of NBD1-K890T shown in panel F was obtained upon re-injection of the sample NBD1-K890T that eluted as a monomer in panel E. For each sample, 200 µl of 100 µM of protein was loaded onto the column. Panel B shows the SDS-PAGE corresponding to the elution profile of NBD1-WT in panel A.


Page 14 of 45

Page 15 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Figure 3. SUR1 NBD1-WT and NBD1-WT-∆ ∆17∆ ∆C give high quality protein NMR spectra, allowing for backbone NMR resonance assignment. (Ai) Overlay of the 2D 15N-1H TROSY-HSQC64 NMR spectra of NBD1WT (300 µM) with NBD1-WT-∆17∆C (300 µM) in the NMR buffer at 30 °C at 600 MHz. (Aii) selected region of the overlaid spectra shown in Ai. The spectrum of NBD1-WT is in the background with resonances of backbone nuclei, as well as those from side chain nuclei from Trp, Asn, and Gln residues, shown in black. The green resonances are of opposite sign, caused by spectral aliasing, and are possibly from Arg NεHε side chain correlations. The spectrum of NBD1-WT-∆17∆C is shown in the foreground. The red and blue peaks in the NBD1-WT-∆17∆C spectrum correspond to the black and green resonances, respectively, in the NBD1-WT spectrum. Assignments for selected resonances in the NBD1-WT-∆17∆C are labeled. Resonance assignments for the indole HN resonances are indicated with a prime symbol (e.g. W778’ and W928’) to distinguish them from backbone HN resonances. (B) Schematic ribbon diagram of the homology model of hSUR1 NBD1 is colored light blue for residues with resonance assignments, gray for residues with no resonance assignments. Residues encoded by exon 17 that are missing in NBD1-WT-∆17∆C are coloured gray. Pro residues are also indicated in gray, as these residues do not give signals in the NH-based NMR experiments, such as the two-dimensional 1H-15N TROSY-HSQC.

The 2D 15N-HSQC-TROSY spectra of NBD1-WTand NBD1-WT-∆17∆C are presented in Figure 3, showing resonance dispersion in the 1H-dimension from 6.5 ppm to 11 ppm that is typical of a folded protein. Of the 269 resonances expected from backbone NH groups for NBD1-WT, 219 are visible in the spectrum. The spectrum also indicates that hSUR1 NBD1 15 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

possesses regions of disorder, as there are a number of intense resonances centered at 8.2 ppm in the 1H dimension. PONDR analysis87-89 indicates that residues Q937-L956, which comprise the C-terminal extension62 in SUR1 NBD1, and S741-R765 are disordered. Residues S742-S753 and P754-R765 are encoded by exon 17 and exon 18, respectively, and connect the β-sheet and α/β subdomains of NBD1. Removal of disordered residues Q937-L956 and S742-S753 in NBD1WT-∆17∆C results in disappearance of many of the intense resonances around 8.2 ppm in the 1H dimension. The high quality of the NBD1-WT-∆17∆C spectra and decreased overlap due to the removal of many disordered resonances enabled resonance assignments of SUR1 NBD1 to be obtained. Resonance assignments were obtained for 88% of backbone HN resonances of NBD1WT-∆17∆C. The similarity between spectra NBD1-WT and NBD1-WT-∆17∆C allowed for the straightforward transfer of most HN resonances assignments. Assignments were also obtained for two of the Trp indole resonances (labeled in the spectra as W778’ and W928’) through mutagenesis. The secondary structure propensity (SSP) scores90 derived from 13Cα and 13Cβ chemical shifts (Figure S1), indicate that the secondary structure of SUR1 NBD1 is very similar to that observed for other NBD proteins,91 and is also very similar to the secondary structure determined for SUR1 NBD1 in cryo-EM structures of the pancreatic KATP channel.56, 57 Notably, the isolated SUR1 NBD1 possess all of the structural elements found in NBD1 in the intact KATP channel, which is in contrast to the isolated NBD1 from the TM287/TM288 transporter. Structural studies indicate that the β-sheet subdomain in the isolated TM287 NBD1 is disordered, and is only folded in the context of the full TM287/TM288 heterodimeric transporter.12, 92 In contrast, the isolated SUR1 NBD1 possesses all of the structural elements found for NBD1 in the intact KATP channel. Thus, structural changes observed for isolated NBD1 with the K890T mutation are also likely present in the KATP channel. In order to determine whether NBD1 was a monomeric protein at high concentrations, such as those used for NMR experiments (> 0.2 - 0.5 mM), we determined 15N R2 relaxation rates for SUR1 NBD1-WT at 0.5 mM (Figure 4). 15N R2 relaxation rates were calculated for 31 isolated resonances that have 1H chemical shifts of less than 7.7 ppm or greater than 8.5 ppm and are derived from structured residues. Resonances with 1H chemical shifts between 7.7 ppm and 8.5 ppm in the 1H dimension were excluded from the analysis because of resonance overlap, which would compromise analysis of the relaxation data. Further, many resonances in this region of the spectrum are derived from disordered regions in the protein (Figure 3), and thus would 16 ACS Paragon Plus Environment

Page 16 of 45

Page 17 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

give longer R2 relaxation rates that are typical of molecules smaller than NBD1. The correlation time (τc) was calculated from the 15N R2 relaxation rates using only the J(0) from the spectral density function, as it dominates the 15N R2 relaxation rate for proteins.93 In this calculation we assumed an order parameter (S2) of 0.85, which is the typical value for a folded protein.69 The τc for SUR1 NBD1-WT was determined to be 22.9 ± 3.0 ns, similar to the τc calculated for monomeric SUR2A NBD1.94 Thus, the 15N R2 relaxation data indicates the wild type SUR1 NBD1 samples (at concentrations of ≤ 0.5 mM) used in these studies are monomeric. The high quality of the NMR data for SUR1 NBD1-WT indicates that we can use NMR spectroscopy to probe structural changes in NBD1 resulting from disease-causing mutations in NBD1. Figure 4. 15N R2 relaxation data for 0.5 mM NBD1-WT. (A) Selected resonances from the 15N1

H correlation spectrum recorded

with a delay time of 2 ms and with the pulse sequence used to determine 15N R1ρ rates. (B) 15N R1ρ decay curves for peaks shown in A. The 15N R1ρ rates were used to determine 15N R2 rates.


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

The K890T mutation causes aggregation and conformational changes in NBD1. The size exclusion column elution profile for NBD1 bearing the K890T mutation (NBD1-K890T) indicates that the mutation causes partial aggregation of the protein (Figure 2C). NBD1-K890T elutes from the size exclusion column in multiple peaks. The elution profile of NBD1-K890T possesses a peak at the void volume (7.8 mL). However the K890T-NBD1 elution profile also shows a peak at 10.2 mL that corresponds to monomeric NBD1 (Figure 2A,B). The high absorbance reading for the fraction of NBD1-K890T that elutes at the void volume is in part due to aggregation of the protein, as aggregates absorb more strongly due to scattering of light. Notably, aggregation of NBD1-K890T can be reduced by pre-treating samples with 12.5 % (v/v) glycerol and 15 mM MgATP prior to loading on the size exclusion column (Figure 2E). Glycerol is a protective osmolyte that stabilizes the folded state of proteins,95-98 including SUR2A NBD1.63 Addition of MgATP also stabilizes SUR2A NBD163 and SUR1 NBD1 (see below). Notably, pre-treating samples of NBD1-WT with 12.5 % (v/v) glycerol and 15 mM MgATP does not change the elution profile of the wild type protein (Figure 2D). Furthermore, the monomeric form of NBD1-K890T is stable, as protein from the monomeric peak does not partition in multiple fractions when re-injected on the size exclusion column (Figure 2F). In addition, NMR spectra of SUR1 NBD1-WT and NBD1-K890T samples taken directly from the monomeric elution fraction from the size exclusion column (Figure 2D,E) without concentrating the samples further are identical to more concentrated samples of SUR1 NBD1-WT and NBD1K890T, respectively (Figure S2). Note that all subsequent NBD1-K890T experiments were performed with monomeric NBD1-K890T. To further investigate the cause of aggregation of NBD1-K890T, we performed thermal denaturation studies of wild type NBD1 and NBD1-K890T with varying concentrations of MgATP. The fluorescence denaturation curves for NBD1-WT and NBD1-K890T proteins show very steep baselines, possibly due to the fact that the human SUR1 NBD1 proteins contain five Trp residues that are located throughout the protein. The steep baselines preclude fitting the denaturation curves to obtain melting temperatures (Tm values). However, comparison of the sigmoidal region of the curves shows that NBD1-K890T unfolds at lower temperatures than NBD1-WT at all MgATP concentrations, and particularly at low MgATP concentrations. Further, estimation of the Tm values by determining the midpoint of the transition portion of the curve indicates that NBD1-K890T possess Tm values that are 3.5 – 4.2 °C lower than those 18 ACS Paragon Plus Environment

Page 18 of 45

Page 19 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

observed for the NBD1-WT at all MgATP concentrations (Figure 5). Note that melting curves for NBD1 proteins in absence of MgATP were not sigmoidal, precluding determination of Tm values. The decreased thermal stability imparted by the K890T mutation may cause partial unfolding of the NBD1, leading to aggregation of NBD1-K890T in vitro.

Figure 5. The K890T mutation decreases the thermal stability of NBD1. Intrinsic Trp fluorescence denaturation curves of 2 µM NBD1-WT (solid circles) and K890T-NBD1 (open circles) in the presence of 0.1 mM (A), 0.5 mM (B) and 5 mM (C) MgATP. The Tm values are 35.9 ± 0.5 °C, 39.6 ± 0.4 °C, and 44.3 ± 0.5 °C for NBD1-WT in the presence of 0.1 mM MgATP, 0.5 mM MgATP, and 5.0 mM MgATP, respectively. Tm values for NBD1-K890T are 31.7 ± 0.4 °C, 36.0 ± 0.11 °C, and 40.1 ± 0.3 °C in the presence of 0.1 mM MgATP, 0.5 mM MgATP, and 5.0 mM MgATP, respectively.

The K890T mutation also affects the conformation of many residues in NBD1, which could also affect interaction of NBD1 with other regions in SUR1, such as the coupling helices and NBD2. Comparison of NMR spectra of NBD1-WT and NBD1-K890T in the presence of MgATP shows that the K890T mutation results in chemical shift changes for many (> 100) backbone resonances, the majority of which are derived from structured residues in the protein (Figure 6A,B). As expected, large-scale chemical shift changes are observed for resonances from backbone NH groups of V887-L894, all of which are close (within 6 Å) to the site of the mutation (Figure 6C). The K890T mutation also results in chemical shift changes for residues D855-D861 located in the adjacent loop, which is known as the D loop. The SUR1 NBD1 homology model indicates that the side chains of K890 and F857 are close together, in a potential cation-pi interaction. Removal of the amino group with the K890T mutation would disrupt this interaction, leading to altered protein conformation and the observed chemical shift changes in HN resonances of many NBD1 residues. For example, large chemical shift changes 19 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

are seen for residues V850, V851, L853, and D854 of the Walker B motif, even though some of these residues are > 10 Å away from K890. The Walker B motif is involved in MgATP binding and hydrolysis.24 Chemical shift changes are also observed for residues of other sites involved in ATP binding, such as G713-V715, G718, and S720 in the Walker A motif and Y772, W778, N781 in the Q loop, which are up to 21 Å away from the mutation site. The NMR data indicates that the K890T mutation also affects residues in the α-helical subdomain, including those in and adjacent to the signature sequence (e.g. G827-L830, Q834, Q836). Some of these residues also contact NBD2. Resonance assignment of the entire signature sequence was not possible due to significant broadening of resonances from these residues. Finally, the K890T mutation also affects NBD1 residues that contact coupling helix 4. In addition to the aforementioned Y772, W778, and N781, chemical shift changes are also seen for I828 and L830. The number and magnitude of chemical shift changes for residues distant from the mutation site indicates that the K890T mutation causes global conformational changes in NBD1, which may affect binding of NBD1 to MgATP, NBD2, and/or the coupling helices. In contrast to the gross spectral changes in NBD1 from the K890T mutation, mutation of the surface-exposed His 863 to Thr, a mutation that causes diabetes and hence is not expected to decrease channel gating,99 results in limited changes in the NBD1 spectrum (Figure S3). The H863T mutation causes chemical changes in much fewer resonances in the NBD1 spectrum compared to the K890T mutation. Further, the magnitudes of most of the chemical shift changes imparted by the H863T mutation are very small (≤10 Hz). Chemical shift changes of ≥ 20 Hz are observed for only 3 resonances in the spectrum of NBD1-H863T. In contrast, the K890T mutation causes chemical shift changes of ≥ 20 Hz in 28 resonances. Thus, differences in spectra of NBD1-WT and NBD1-K890T result from perturbation of the NBD1 structure, and may be observed for other mutations that result in impaired trafficking or loss-of-gating function such as those that cause hyperinsulinism. Testing this hypothesis requires structural studies of many NBD mutations that cause hyperinsulinism and diabetes. In addition, the spectrum of NBD1 containing mutation of the surface exposed Trp 778, which was acquired in order to assign the Trp indole resonances, is also very similar to the spectrum of the wild type protein (data not shown).


Page 20 of 45

Page 21 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Figure 6. NMR data show that K890T mutation affects residues throughout NBD1. (Ai) The 2D15N-1H TROSY-HSQC NMR spectra of NBD1-WT (300 µM) and NBD1-K890T (150 µM) are overlaid. (Aii) Selected region of the overlaid spectra shown in Ai. The spectrum of NBD1-WT is in the background coloured as in Figure 3. The spectrum of NBD1-K890T is in the foreground. Resonances coloured red and blue correspond to the black and green resonances, respectively, in the spectrum of NBD1-WT. Assignments for selected resonances in NBD1-WT that exhibit chemical shift changes with the K890T mutation are labeled. (B) Chemical shift mapping of changes with the K890T mutation to specific residues in NBD1. Cα atoms of residues that chemical shift changes are shown as spheres colored from light pink, to highlight the smallest changes (∆δtot= 8 –10 Hz), to dark pink for the largest changes (∆δtot ≥ 25 Hz). The side chain of K890 is shown in yellow. The side chain of F857 is also shown, in dark pink, to highlight the potential cation-pi interaction between K890 and F857.

The NMR data described above highlight structural changes in NBD1-WT imparted by the K890T mutation in the MgATP bound state of the protein. Unfortunately, as seen for SUR2A NBD1,61 samples of SUR1 NBD1 lacking MgATP give NMR spectra that are significantly broadened (Figure S4A), possibly due to aggregation of the apo proteins at the high protein concentrations (≥ 100 µM) and temperatures (25 °C – 30 °C) required for NMR studies of SUR NBDs. Hence, assessing how the K890T mutation affects the structure of apo NBD1 is not possible by NMR spectroscopy. Because NBD1 proteins with and without MgATP yield high 21 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

quality fluorescence spectra, including at low temperatures (e.g. 15 °C) where the apo proteins are more stable, we also used Trp fluorescence quenching studies to probe the conformational changes in NBD1 imparted by the K890T mutation. The much lower concentration of NBD1WT and NBD1-K890T (2 µM) used in the fluorescence studies also ensures that the apo proteins are monomeric, which is confirmed for each sample by size exclusion chromatography used to exchange the NBD1 proteins into the required buffers (Figure 2 and Experimental Procedures). Changes in fluorescence of Trp residues are widely used to probe conformational changes in proteins.78, 100, 101 The five Trp residues in SUR1 NBD1 are located throughout the protein (Figure 1) and have varying degrees of solvent exposure, according to the homology model of SUR1 NBD1. Thus, the Trp residues are good reporters for assessing structural changes throughout the protein. Dynamic quenching of Trp fluorescence depends on the exposure of the Trp residue as well as on its local environment.100, 101 For example, I- ions will effectively quench an exposed Trp residue close to positively charged groups, such as the side chains of Arg and Lys residues, but will not affect the fluorescence of Trp residues near negatively charged amino acids. Acrylamide will quench surface-exposed Trp residues surrounded by hydrophobic residues. In addition, acrylamide can access the hydrophobic core and hence quench the fluorescence from buried Trp residues. Cs+ will quench an exposed Trp residue close to negatively charged groups. Thus, differences in fluorescence quenching are good indicators of changes in conformational and dynamics in NBD1. The fluorescence emission spectrum of SUR1 NBD1-WT shows a λmax of 345 nm, indicating that most of the fluorescence signal arises from exposed Trp residues.78, 101, 102 Addition of increasing amounts of a quencher (I- or acrylamide) results in successive decreases in the fluorescence signal. As for other proteins containing multiple Trp residues, such as Pglycoprotein,78, 101 Stern-Volmer plots for SUR1 NBD1-WT and NBD1-K890T are linear (Figure 7). It is likely that some of the Trp residues in the protein are not affected by the quencher, either because they are not surface exposed or because they are in environments not compatible with the specific quencher as explained above. Fluorescence quenching data with Ishow differences between NBD1-WT and NBD1-K890T in absence and presence of MgATP (Figure 7A, Table 1). The larger KSV values for NBD1-K890T (apo, 2.27 ± 0.33 M-1; MgATPbound, 1.70 ± 0.26 M-1) compared with NBD1-WT (apo, 1.79 ± 0.18 M-1; MgATP-bound, 1.33 ± 0.07 M-1) indicates greater accessibility of one or more Trp residues located in a positively22 ACS Paragon Plus Environment

Page 22 of 45

Page 23 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

charged environment in NBD1-K890T in both apo and MgATP-bound states. An examination of the surface potential of the homology model of SUR1 NBD1 suggests that W778 (and possibly W928) are affected by I-, as they are located near positively charged residues, in contrast to other Trp residues (W688, W739, W899) which are near negatively charged or non-polar residues (Figure 7E). Notably, both the backbone and Trp indole HN NMR resonances for W778 and W928 change with the K890T mutation. In contrast, chemical shift changes are not observed for the other Trp indole resonances (W688’, W739’, W899’) or for the backbone HN resonances for W739. The overlap in the spectra precludes assessing changes for the backbone HN resonances of W688 and W899. Further support for the contribution of W778 to fluorescence quenching of NBD1-WT and NBD1-K890T is seen by the decrease in the KSV values for the two proteins containing the W778F mutation in the presence of MgATP to 1.11 ± 0.09 M-1 and 1.47 ± 0.12 M1

, respectively (Figure 7C,D and Table 1). Mutation of W778 to Phe also affects the KSV value

for NBD1 in the absence of MgATP, suggesting that W778 contributes to Trp quenching in the apo protein. In contrast, mutation of W688 or W928 to Phe does not affect the KSV values for NBD1 in the presence or absence of MgATP. The difference in the KSV values for NBD1W778F and NBD1-W778F/K890T indicates that additional Trp residues contribute to quenching of the K890T mutant, such as W928. However, the lack of soluble protein obtained for NBD1K890T possessing W688F or W928F mutants precludes determining the contribution of those Trp residues to quenching of NBD1 with the K890T mutation. Soluble protein could also not be obtained for NBD1 proteins with mutations of W739 or W899 to Phe. In contrast to that observed for I- quenching, KSV values for acrylamide quenching are similar for NBD1-WT and NBD1-K890T in the presence of MgATP (Figure 7B, Table 1), indicating that additional Trp residues are not affected by the K890T mutation for the MgATPloaded proteins. However, KSV values for acrylamide are increased for NBD1-K890T in absence of MgATP. Destabilization of the structure of apo NBD1 imparted by the K890T mutation, including, but not limited to removal of the K890-F857 cation-pi interaction, could cause changes in exposure of Trp residues in hydrophobic environments. The KSV values obtained with Cs+ are very small (e.g. 0.12 – 0.75 M-1) indicating that Cs+ is not an effective quencher of NBD1. Together, the fluorescence quenching and current NMR studies demonstrate that the K890T mutation alters the conformation of residues near and far from the site of the mutation, in both apo and MgATP-bound states. 23 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 7. The K890T mutation causes changes in Trp quenching in NBD1. Stern-Volmer plots for fluorescence quenching of the Trp residues in NBD1-WT (black) and NBD1-K890T (red) by I- (A) or acrylamide (B) in the fluorescence buffer. Data from fluorescence quenching in the absence and presence of 5 mM MgATP are shown as open and filled circles, respectively. The fit of the Stern-Volmer plots is shown in a solid line for MgATP-loaded NBD1 proteins and in a dashed line for apo NBD1 proteins. Fluorescence intensities for both acrylamide and Iquenching were corrected for dilution, scattering, and ionic strength. (C) Trp quenching studies of NBD1 with mutation of individual Trp residues to Phe in the presence of MgATP. Trp quenching data is shown for NBD1W688F (gray open squares and dotted line), NBD1-W778F (grey filled squares and dotted line), and NBD1-W928F (light gray filled circle and dotted line). Data for additional Trp mutants could not be obtained due to insolubility of the proteins. The data for NBD1-WT from panel A is shown for comparison. (D) Trp quenching studies of NBD1-


Page 24 of 45

Page 25 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

K890T containing the W778F mutation (red closed square and dotted line) in the presence of MgATP. The data for NBD1-K890T from panel B and NBD1-W778F C are shown for comparison. (E) Surface representation of the homology model of NBD1-WT with blue and red representing positive and negative electrostatic potential, respectively. The ATP binding site of NBD1 is shown on the left while the opposite face of NBD1 is shown on the right. Black arrows highlight the side chain of the Trp residues. The calculated accessible surface area of each Trp side chain is given in parentheses.

Table 1. Stern-Volmer constants for SUR1 NBD1 proteins NBD1 protein WT K890T W778F W928F W688F W778F/K890T

KI quenching Ksv (M-1) MgATP (5mM) EDTA (5mM) 1.33 ± 0.07 n = 5 1.79 ± 0.18 n = 4 1.70 ± 0.26 n = 4 2.27 ± 0.33 n = 6 1.11 ± 0.09 n = 3 1.35 ± 0.17 n = 3 1.40 ± 0.15 n = 3 1.67 ± 0.11 n = 3 1.33 ± 0.17 n = 2 1.61 ± 0.17 n = 2 1.47 ± 0.12 n = 3 N.D.

Acrylamide quenching Ksv (M-1) MgATP (5mM) EDTA (5mM) 4.83 ± 0.18 n = 2 4.58 ± 0.22 n = 2 4.96 ± 0.26 n = 2 4.10 ± 0.04 n = 2 4.56 ± 0.28 n = 2 4.25 ± 0.13 n = 2 4.51 ± 0.16 n = 2 4.16 ± 0.10 n = 2 5.45 ± 0.19 n = 3 5.05 ± 0.35 n = 2 N.D. N.D.

CsCl quenching Ksv (M-1) MgATP (5mM) No MgATP 0.66 ± 0.08 n = 2 0.75 ± 0.10 n = 2 0.66 ± 0.10 n = 2 0.59 ±0.12 n = 2 0.27 ± 0.06 n = 3 0.63 ± N.D. * 0.12 ± 0.01 n = 2 0.59 ± N.D * 0.63 ± 0.09 n = 2 0.49 ± N.D. * N.D. N.D.

N.D. is not determined. *n=1

The K890T mutation decreases the MgATP binding affinity of NBD1. The NMR and fluorescence quenching data indicate that the K890T mutation alters the conformation of residues involved in MgATP binding, such as residues in the Walker A, Walker B, and the Q loop (also known as the γ-phosphate linker103) (Figure 6). Therefore, we sought to determine whether the K890T mutation alters the affinity of NBD1 for MgATP. We used a fluorescentlylabeled analogue of ATP, MANT-ATP. MANT-ATP has a methylanthraniloyl group on the ribose of the nucleotide and has been employed to study nucleotide binding to several proteins, including ABC transporters.104-106 Addition of MANT-ATP to NBD1 results in a quenching of the intrinsic Trp fluorescence of the protein (at 345 nm), when the excitation wavelength is 295 nm (Figure 8A). In addition, the fluorescence spectra of samples containing NBD1 and increasing concentrations of MANT-ATP also possess an increase in fluorescence at 440 nm. The decrease of the Trp fluorescence (at 345 nm) and increase of the MANT-ATP fluorescence (at 440 nm) is due to fluorescence resonance energy transfer between a Trp residue in NBD1 and the MANT group of bound MANT-ATP. Thus, the binding affinity of MANT-ATP can be determined from the fluorescence changes at either 345 nm or 440 nm,107 but with different analyses. The decrease in NBD1 fluorescence at 345 nm with increasing amounts of MANTATP follows a hyperbolic saturation curve (Figure 8B). Dissociation constants (Kd) obtained from the fluorescence quenching curves show tight binding of MANT-ATP to NBD1-WT (0.11 25 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

± 0.03 µM), as is also seen the interaction of other NBDs with the ATP analogue TNP-ATP.62, 63, 94, 108

Comparison of the NMR spectra of NBD1 with MANT-ATP and with ATP shows

chemical shift changes in several residues (Figure S5), including some in the β-sheet subdomain that are not expected to bind MgATP from structures of other NBDs.91 These chemical shift changes may reflect differences in ATP and MANT-ATP binding to NBD1, or differences in conformation of NBD1 with the different nucleotides. Nonetheless, the NMR spectra and hence conformation of NBD1 is similar in the presence of ATP and MANT-ATP, making MANT-ATP a useful probe for nucleotide binding studies of wild type and mutant NBDs. Notably, the K890T mutation results in a reduction in the nucleotide binding affinity of NBD1 (Kd = 0.63 ± 0.11 µM). Reduction of MgATP binding has also been observed for other SUR1 NBD mutations that cause congenital hyperinsulinism.109 Changes in the fluorescence emission at 440 nm also demonstrate that the K890T mutation decreases the affinity of the protein for nucleotide. A plot of the fluorescence at 440 nm as a function of MANT-ATP concentration (Figure 8C) shows a hyperbolic saturation curve at low MANT-ATP concentrations, corresponding to the fluorescence of bound MANT-ATP, and a straight line at high MANT-ATP concentrations that corresponds to the fluorescence of free MANT-ATP. The Kd value determined for the MANT-ATP/NBD1-WT interaction using the fluorescence increase at 440 nm (0.16 ± 0.03 µM) is the same as that determined by monitoring fluorescence quenching at 345 nm. The lower affinity of NBD1-K890T for MANT-ATP does not produce the hyperbolic curve at low MANT-ATP concentrations (Figure 8C, open circles), which precludes determination of the Kd value for nucleotide binding to NBD1-K890T from the increase in MANT-ATP fluorescence. Increasing the concentration of NBD1-K890T to allow for greater fluorescence enhancement at low nucleotide concentrations can not be accomplished due to precipitation of the protein in the nucleotide-free state at higher protein concentrations (e.g. 10-50 µM). Nonetheless, it is clear from that NBD1-K890T has at least a 5-to-6-fold reduction in affinity for nucleotide compared with NBD1-WT. Binding of MANT-ATP decreases 2.5-fold in absence of Mg2+ (Kd = 0.28 ± 0.01µM) (Figure S6), consistent with studies that indicate that nucleotide binding to NBD1 is possible without Mg2+.32 However, NMR spectra of NBD1 in the presence of 5 mM ATP but lacking Mg2+ yielded spectra that are significantly broadened, identical to NBD1 spectra lacking MgATP (Figure S4). Note that NBD1 samples for these Mg2+-free studies were exchanged into the 26 ACS Paragon Plus Environment

Page 26 of 45

Page 27 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

fluorescence buffer by gel filtration chromatography. The buffer was treated with Chelex 100 resin to remove any residual metals prior to equilibration of the column.

Figure 8. The K890T mutation reduces the affinity of NBD1 for MgATP. (A) Fluorescence emission spectra of 2 µM NBD1-WT in the absence (close circles) in the presence (open circles) of 10 µM MANT-ATP. The emission spectra of MANT-ATP (solid line) and buffer (dashed line) are also shown. Binding of NBD1-WT (closed circles) and NBD1-K890T (open circles) to MANT-ATP as monitored by the quenching of the Trp residues at 345 nm (B) and increase of fluorescence due to the FRET effect at 440 nm (C). The concentrations of NBD1-WT and NBD1K890T were 0.25 µM. MANT-ATP titration data were fit assuming a 1:1 complex for NBD1/nucleotide interaction. Note that experiments done using 0.05 µM NBD1-WT, rather than 0.25 µM, resulted in the same Kd value obtained.

Severe hyperinsulinism-causing mutations result in aggregation of NBD1. In contrast to the K890T mutation, NBD1 proteins bearing severe hyperinsulinism-causing mutations (G716V, R842G) produce large aggregates under the same conditions that allow for monomeric NBD1-WT and NBD1-K890T (Figure 9). NBD1-R842G elutes from the gel filtration column at 7.8 mL (Figure 9A), which corresponds to the void volume of the Superdex 75 column. This shows that even at the low concentrations (of ~10 µM) at which proteins elute from the size exclusion column the majority of the NBD1-R842G is aggregated, having a molecular mass of ≥75 kDa. NBD1 with the mutation G716V also shows a similar elution profile on the Superdex 75 column. Thus, these mutant NBD1 proteins do not produce detectable amounts of monomeric protein, possibly resulting from unfolding of the NBD1 protein. Mutation of G716, which is a conserved residue in the Walker A motif, likely inhibits ATP binding and leads to subsequent destabilization of the NBD as seen for SUR2A NBD1.63 Mutation of R842, which is located in the α5 helix of the α-helical subdomain, to Gly likely disrupts the secondary structure and 27 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

destabilizes the domain, as Gly residues are not favoured in α-helices.110 Because folding of ABC transporters may involve sequential folding of individual domains during translation,103 the mutations G716V and R842G may also prevent proper folding of SUR1, and consequently assembly and trafficking KATP channel. Notably, the G716V mutation results in disrupted trafficking of the KATP channel that cannot be rescued with diazoxide.52 The effect of the R842G mutation on KATP channel trafficking or gating has not yet been determined. In keeping with the observed high molecular weight aggregates, NBD1 proteins bearing the hyperinsulinism mutations G716V and R842G give spectra that contain only a few resonances centered about 8.2 ppm in the 1H dimension (Figure 9B and Figure S7, red). These intense resonances, which are also observed in the spectrum of NBD1-WT, originate from disordered regions of the protein. Resonances with 1H chemical shift values greater than 8.5 ppm or less than 7.7 ppm, which are derived from structured residues, are not observed in spectra of NBD1-R842G (Figure 9B) or NBD1-G716V (Figure S7). The lack of monomeric protein produced for these NBD1 mutants precluded their further analysis.

Figure 9. Severe congenital hyperinsulinism-causing mutations cause aggregation of NBD1 in vitro. (A) The size exclusion elution profile of NBD1-R842G shows one peak at the void volume, indicating the NBD1-R842G exists as an oligomer of at least 75 kDa. As for NBD1-WT and NBD1-K890T (Figure 2), a total of 200 µl of 100 µM of protein was loaded onto the column, which was run in the fluorescence buffer. (B) Overlay of the NMR spectra of NBD1-WT (300 µM) and NBD1-R842G (100 µM). The 15N-1H TROSY-HSQC spectrum of NBD1-WT is in the background and is coloured as in Figures 3 and 6A. The spectrum of NBD1-R842G is in the foreground with peaks coloured red and blue as done for the spectrum of NBD1-K890T in Figure 6A.


Page 28 of 45

Page 29 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Discussion Here, we have used NMR and fluorescence spectroscopy, and biochemical data to probe the molecular defects in SUR1 NBD1 with different hyperinsulinism-causing mutations. In contrast to past studies on the SUR1 NBDs,111 we can obtain monomeric wild type NBD1 samples at high concentrations that give high quality NMR and fluorescence data, allowing for analysis of the effects of NBD1 mutations. Secondary structure analysis of NBD1 based on the NMR chemical shifts shows that the structures of the isolated NBD1-WT and NBD1 in the intact KATP channel are very similar. Thus, structural changes in isolated SUR1 NBD1 imparted by the K890T mutation likely also occur for NBD1 in KATP channels. Further, our near-complete backbone NMR resonance assignments of NBD1-WT enable analysis of the structural changes from mutations to be determined at the level of individual residues. Our data indicate that different mutations cause different molecular defects in NBD1. The K890T mutation results in multiple defects in NBD1, including altered protein structure and decreased thermodynamic stability, and reduced nucleotide binding affinity of the protein. The severe hyperinsulinismcausing mutations G716V and R842G cause aggregation of NBD1, likely due to disrupted structure and subsequent protein unfolding. Residues G716, R842, and K890 are located in different regions in NBD1. Residue G716 is the second conserved Gly in the Walker A motif (GXXGXGK[S/T]91 with the affected Gly in bold) and is located in the loop connecting the β3 strand and α1 helix in the ATP binding subdomain. Structures of NBDs from other ABC transporters indicate that the backbone HN of the Gly residue at this position hydrogen bonds to the β-phosphate of the ATP.112-115 Mutation of G716 to the larger Val residue may disrupt the protein structure in this region, by altering the conformation of the β3 strand-α1-helix connecting loop in addition to other structural perturbations, thus compromising ATP binding. Decreased ATP binding reduces the thermodynamic stability of SUR1 NBD1 (and SUR2A NBD163), leading to NBD1 aggregation in vitro. In addition, altered structure and lack of MgATP binding by NBD1 bearing the G716V mutation would also compromise binding of NBD1 to NBD2, which may affect folding of the entire SUR1 protein and lead to the observed trafficking defect of KATP channels containing SUR1 with the G716V mutation.52 Notably, the Walker A is a hot spot for hyperinsulinism-causing mutations. Mutation of G716 to Asp causes hyperinsulinism,45, 53 as does mutation of the NBD2 homologous residue 29 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

G1382, to Ser.40, 41, 116, 117 Studies of KATP channels possessing the G1382S mutation show reduced stimulation of KATP channel opening by MgADP and a reduced response to diazoxide.116, 117 Mutation of other Walker A residues (e.g. K719P in NBD1 and G1379S in NBD2) also has detrimental consequences to KATP channel function, including reduced opening of KATP channels in response to MgADP and compromised trafficking of the KATP channel to the plasma membrane.53, 118Additional Walker A mutations (e.g. K719T, G1379R, G1384R, and K1385Q) also cause disease,40, 41, 45, 116, 119, 120 but their effects on NBD function, and associated KATP channel trafficking and gating have yet to be characterized. In addition to causing the observed in vitro aggregation of NBD1, the altered structure of NBD1 imparted by the R842G mutation likely compromises interaction of NBD1 with other regions of SUR1, such as with a Glu (E1209) in coupling helix 4 as predicted from our homology model of SUR1 (Figure S8). Notably, an Arg residue at this position is conserved among all human C-subfamily ABC (ABCC) proteins, as well as in TAP1, P-glycoprotein, and many bacterial ABC proteins, highlighting its importance. Homology models of SUR1 (Figure 1, Figure S8, and reference 121) indicate that R842 is involved in a cation-pi interaction with W778, which is also conserved in the NBD1 from all human ABCC proteins. Homologous cation-pi interactions are observed in crystal structures of NBD1 from MRP1122 and CFTR.60, 123 Residue W778 is located in the Q loop, which also contains the Gln residue necessary for binding the γ-phosphate of ATP. Thus, interactions of R842 and W778 may be necessary to position the Gln residue of the Q loop for productive ATP interactions, which lead to dimerization with NBD2. This critical cation-pi interaction is lost with the R842G mutation. Notably, mutation of the homologous residue hSUR1 NBD2, R1494, also disrupts trafficking of KATP channels,124 suggesting that cation-pi interactions of R1494 with an aromatic residue is necessary in order for NBD2 to make productive interactions with ATP. Residue R1494 may also interact with residues in the coupling helices. Residue K890 is immediately C-terminal to the conserved His residue in the H loop. The H loop in NBD1 is involved in binding the γ-phosphate of the ATP bound to the NBD1 composite site, the Asp residue of the Walker B motif of NBD1 that also interacts with the bound ATP, and the conserved Asp from the D loop of NBD2.91 The analogous interactions are formed by the H loop of NBD2, including binding between the NBD2 H loop and the NBD1 D loop. Notably, many of the largest chemical shift changes observed with the K890T mutation are for 30 ACS Paragon Plus Environment

Page 30 of 45

Page 31 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

residues of the D loop of NBD1 (D855-D861), implying that they adopt very different environments and conformations in NBD1-K890T. Large chemical shift changes are also seen for F857, which is immediately N-terminal to the D loop and is predicted to form a cation-pi interaction with K890 according to the homology model of hSUR1 NBD1. Further, Lys and Phe residues are conserved at these positions in SUR2 and across different species of SUR1 and SUR2, highlighting the importance of this interaction in stabilizing the H loop. Thus, mutation of K890 likely alters the H loop conformation, which is propagated throughout the protein, explaining the 5-to-6-fold decrease in nucleotide binding observed for the K890T mutation. Altered structures of the H loop and D loop of NBD1 imparted by the K890T mutation could affect NBD1/NBD2 dimerization and subsequent MgATP hydrolysis, leading to the observed decreased KATP channel activity.53 Altered interactions of the H loop with other parts of NBD1 may also underlie the decreased stability of NBD1-K890T, which may be corrected by pharmacological chaperones as done to treat diseases of other ABC proteins.54, 55 Compounds that correct the defects of the K890T mutation may also be useful for correcting KATP channel folding and activity with the G716V and R842G mutations. While current small molecule therapy involves administering diazoxide, most hyperinsulinism patients do not respond to diazoxide40, 41, 52, 125 and are instead treated by pancreatectomy.126 The chemical shift changes of residues in the Q loop (Y772, W778, N781) and changes in Trp fluorescence quenching from the K890T mutation suggest that this mutation may also affect binding of NBD1 to coupling helix 4, as W778 is at the coupling helix interface in our SUR1 models. Disrupted NBD/coupling helix interactions would also compromise KATP channel gating, as these contacts are needed to transfer information from MgATP binding and hydrolysis at the NBDs to the SUR1 membrane spanning domains, which are ultimately transferred to the Kir6.2 pore. Notably, there are multiple mutations in the predicted SUR1 coupling helices that cause hyperinsulinism.39 The data and methods presented here for studying SUR1 NBD1 in wild type and mutant states provides a platform to determine how different disease-causing mutations affect the structure, stability, and interactions of SUR1. Such studies will lead to a greater understanding of the molecular defects causing congenital hyperinsulinism.


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Author contributions C. P. A. generated samples, recorded NMR spectra and performed the fluorescence experiments of all NBD1 samples. M.S. obtained initial NBD1-WT construct and generated some samples of NBD1. R.M. acquired the triple resonance NMR data for resonance assignment of NBD1-WT∆17∆C. C.P.A. analyzed all of the fluorescence data, and C.P.A. and V. K. analyzed the NMR data. C.P.A. and V. K. generated the figures, and wrote and edited the manuscript.

Acknowledgements We thank Lewis E. Kay for very helpful discussions regarding resonance assignment of NBD1WT-∆17∆C and for facilitating acquisition of triple resonance NMR data. We thank Dr. John L. Rubinstein for critically reading the manuscript. Dr. Daaf Sandkuijl is acknowledged for assistance with Matlab scripts for nucleotide affinity studies.

Funding This work was funded by grants from the Canadian Institutes of Health Research (CIHR) (MOP106470), the Natural Sciences and Engineering Council of Canada (RGPIN-2015-05372), and the Rare Disease Foundation to V.K. V.K. acknowledges support from an Early Researcher Award from the Ontario Ministry of Economic Development Innovation and CIHR New Investigator Award. C.P.A was supported by an Ontario Graduate Scholarship.

Supporting Information Supporting information includes the following: (1) the secondary structural propensity of SUR1 NBD1; (2) comparison of NMR spectra of NBD1-WT and NBD1-K890T at varying concentrations; (3) comparison of NBD1 of NBD1-WT and NBD1-H863T; (4) spectra of apo NBD1-WT and NBD1-WT with MgATP or ATP alone; (5) NMR spectra of NBD1-WT with MgATPand with Mg-MANT-ATP; (6) MANT-ATP binding data in absence of Mg2+; (7) comparison of NBD1 of NBD1-WT and NBD1-G716V; and (8) a homology model of SUR1. This material is available free of charge via the Internet at http://pubs.acs.org.


Page 32 of 45

Page 33 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

References 1. Aguilar-Bryan, L., Nichols, C., Wechsler, S., Clement, J., Boyd, A., Gonzalez, G., HerreraSosa, H., Nguy, K., Bryan, J., and Nelson, D. (1995) Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion, Science 268, 423-426. 2. Inagaki, N., Gonoi, T., Clement, J. P. t., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., and Bryan, J. (1995) Reconstitution of iKATP: An inward rectifier subunit plus the sulfonylurea receptor, Science 270, 1166-1170. 3. Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., AguilarBryan, L., and Bryan, J. (1997) Association and stoichiometry of K-ATP channel subunits, Neuron 18, 827-838. 4. Inagaki, N., Gonoi, T., and Seino, S. (1997) Subunit stoichiometry of the pancreatic β-cell ATP-sensitive K+ channel, FEBS Lett. 409, 232-236. 5. Shyng, S.-L., and Nichols, C. G. (1997) Octameric stoichiometry of the KATP channel complex, J. Gen. Physiol. 110, 655-664. 6. Fotinou, C., Aittoniemi, J., de Wet, H., Polidori, A., Pucci, B., Sansom, M. S., Venien-Bryan, C., and Ashcroft, F. M. (2013) Tetrameric structure of SUR2B revealed by electron microscopy of oriented single particles, FEBS J. 280, 1051-1063. 7. Mikhailov, M. V., Campbell, J. D., de Wet, H., Shimomura, K., Zadek, B., Collins, R. F., Sansom, M. S., Ford, R. C., and Ashcroft, F. M. (2005) 3-D structural and functional characterization of the purified katp channel complex Kir6.2-SUR1, EMBO J. 24, 41664175. 8. Dean, M., Rzhetsky, A., and Allikmets, R. (2001) The human ATP-binding cassette (ABC) transporter superfamily, Genome Res 11, 1156-1166. 9. Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., and Chang, G. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding, Science 323, 1718-1722. 10. Choudhury, H. G., Tong, Z., Mathavan, I., Li, Y., Iwata, S., Zirah, S., Rebuffat, S., van Veen, H. W., and Beis, K. (2014) Structure of an antibacterial peptide ATP-binding cassette transporter in a novel outward occluded state, Proc. Natl. Acad. Sci. U. S. A. 111, 91459150. 11. Dawson, R. J., and Locher, K. P. (2006) Structure of a bacterial multidrug ABC transporter, Nature 443, 180-185.


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 34 of 45

12. Hohl, M., Briand, C., Grutter, M. G., and Seeger, M. A. (2012) Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation, Nat. Struct. Mol. Biol. 19, 395-402. 13. Hollenstein, K., Dawson, R. J., and Locher, K. P. (2007) Structure and mechanism of ABC transporter proteins, Curr. Opin. Struct. Biol. 17, 412-418. 14. Jin, M. S., Oldham, M. L., Zhang, Q., and Chen, J. (2012) Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans, Nature 490, 566-569. 15. Kadaba, N. S., Kaiser, J. T., Johnson, E., Lee, A., and Rees, D. C. (2008) The high-affinity E. Coli methionine ABC transporter: Structure and allosteric regulation, Science 321, 250253. 16. Lee, J. Y., Yang, J. G., Zhitnitsky, D., Lewinson, O., and Rees, D. C. (2014) Structural basis for heavy metal detoxification by an Atm1-type ABC exporter, Science 343, 1133-1136. 17. Lin, D. Y., Huang, S., and Chen, J. (2015) Crystal structures of a polypeptide processing and secretion transporter, Nature 523, 425-430. 18. Maruyama, Y., Itoh, T., Kaneko, A., Nishitani, Y., Mikami, B., Hashimoto, W., and Murata, K. (2015) Structure of a bacterial ABC transporter involved in the import of an acidic polysaccharide alginate, Structure 23, 1643-1654. 19. Oldham, M. L., Khare, D., Quiocho, F. A., Davidson, A. L., and Chen, J. (2007) Crystal structure of a catalytic intermediate of the maltose transporter, Nature 450, 515-521. 20. Perez, C., Gerber, S., Boilevin, J., Bucher, M., Darbre, T., Aebi, M., Reymond, J. L., and Locher, K. P. (2015) Structure and mechanism of an active lipid-linked oligosaccharide flippase, Nature 524, 433-8. 21. Shintre, C. A., Pike, A. C., Li, Q., Kim, J. I., Barr, A. J., Goubin, S., Shrestha, L., Yang, J., Berridge, G., Ross, J., Stansfeld, P. J., Sansom, M. S., Edwards, A. M., Bountra, C., Marsden, B. D., von Delft, F., Bullock, A. N., Gileadi, O., Burgess-Brown, N. A., and Carpenter, E. P. (2013) Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states, Proc. Natl. Acad. Sci. U. S. A. 110, 97109715. 22. Srinivasan, V., Pierik, A. J., and Lill, R. (2014) Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1, Science 343, 1137-1140. 23. Ward, A., Reyes, C. L., Yu, J., Roth, C. B., and Chang, G. (2007) Flexibility in the ABC transporter MsbA: Alternating access with a twist, Proc. Natl. Acad. Sci. U. S. A. 104, 19005-19010.


Page 35 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

24. Higgins, C. F., and Linton, K. J. (2004) The ATP switch model for ABC transporters, Nat. Struct. Mol. Biol. 11, 918-926. 25. Babenko, A. P., and Bryan, J. (2002) SUR-dependent modulation of KATP channels by an Nterminal Kir6.2 peptide. Defining intersubunit gating interactions, J. Biol. Chem. 277, 43997-44004. 26. Babenko, A. P., and Bryan, J. (2003) SUR domains that associate with and gate KATP pores define a novel gatekeeper, J Biol Chem 278, 41577-41580. 27. Bryan, J., Vila-Carriles, W. H., Zhao, G., Babenko, A. P., and Aguilar-Bryan, L. (2004) Toward linking structure with function in ATP-sensitive K+ channels, Diabetes 53 Suppl. 3, S104-112. 28. Fang, K., Csanady, L., and Chan, K. W. (2006) The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels, J. Physiol. 576, 379-389. 29. Procko, E., O'Mara, M. L., Bennett, W. F., Tieleman, D. P., and Gaudet, R. (2009) The mechanism of ABC transporters: General lessons from structural and functional studies of an antigenic peptide transporter, FASEB J. 23, 1287-1302. 30. Ueda, K., Matsuo, M., Tanabe, K., Morita, K., Kioka, N., and Amachi, T. (1999) Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins, Biochim. Biophys. Acta 1461, 305-313. 31. Zingman, L. V., Alekseev, A. E., Bienengraeber, M., Hodgson, D., Karger, A. B., Dzeja, P. P., and Terzic, A. (2001) Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance, Neuron 31, 233-245. 32. Seino, S., and Miki, T. (2003) Physiological and pathophysiological roles of ATP-sensitive K+ channels, Prog. Biophys. Mol. Biol. 81, 133-176. 33. Bienengraeber, M., Olson, T. M., Selivanov, V. A., Kathmann, E. C., O'Cochlain, F., Gao, F., Karger, A. B., Ballew, J. D., Hodgson, D. M., Zingman, L. V., Pang, Y. P., Alekseev, A. E., and Terzic, A. (2004) ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating, Nat. Genet. 36, 382-387. 34. Nichols, C. G. (2006) KATP channels as molecular sensors of cellular metabolism, Nature 440, 470-476. 35. Ortiz, D., Gossack, L., Quast, U., and Bryan, J. (2013) Reinterpreting the action of ATP analogs on K(ATP) channels, J. Biol. Chem. 288, 18894-18902. 36. Aguilar-Bryan, L., and Bryan, J. (1999) Molecular biology of adenosine triphosphatesensitive potassium channels, Endocr. Rev. 20, 101-135. 35 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 36 of 45

37. Ashcroft, F. M. (2005) ATP-sensitive potassium channelopathies: Focus on insulin secretion, J. Clin. Invest. 115, 2047-2058. 38. Akrouh, A., Halcomb, S. E., Nichols, C. G., and Sala-Rabanal, M. (2009) Molecular biology of K(ATP) channels and implications for health and disease, IUBMB Life 61, 971-978. 39. Aittoniemi, J., Fotinou, C., Craig, T. J., de Wet, H., Proks, P., and Ashcroft, F. M. (2009) Review. Sur1: A unique ATP-binding cassette protein that functions as an ion channel regulator, Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 257-267. 40. Gloyn, A. L., Siddiqui, J., and Ellard, S. (2006) Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism, Hum. Mutat. 27, 220-231. 41. Flanagan, S. E., Clauin, S., Bellanné-Chantelot, C., de Lonlay, P., Harries, L. W., Gloyn, A. L., and Ellard, S. (2009) Update of mutations in the genes encoding the pancreatic betacell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism, Hum. Mutat. 30, 170-180. 42. Nestorowicz, A., Wilson, B. A., Schoor, K. P., Inoue, H., Glaser, B., Landau, H., Stanley, C. A., Thornton, P. S., Clement, J. P. t., Bryan, J., Aguilar-Bryan, L., and Permutt, M. A. (1996) Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews, Hum. Mol. Genet. 5, 1813-1822. 43. Fernandez-Marmiesse, A., Salas, A., Vega, A., Fernandez-Lorenzo, J. R., Barreiro, J., and Carracedo, A. (2006) Mutation spectra of ABCC8 gene in Spanish patients with hyperinsulinism of infancy (HI), Hum. Mutat. 27, 214. 44. Dunne, M. J., Cosgrove, K. E., Shepherd, R. M., Aynsley-Green, A., and Lindley, K. J. (2004) Hyperinsulinism in infancy: From basic science to clinical disease, Physiol. Rev. 84, 239-275. 45. Bellanne-Chantelot, C., Saint-Martin, C., Ribeiro, M. J., Vaury, C., Verkarre, V., Arnoux, J. B., Valayannopoulos, V., Gobrecht, S., Sempoux, C., Rahier, J., Fournet, J. C., Jaubert, F., Aigrain, Y., Nihoul-Fekete, C., and de Lonlay, P. (2010) ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism, J. Med. Genet. 47, 752-759. 46. Arnoux, J. B., Verkarre, V., Saint-Martin, C., Montravers, F., Brassier, A., Valayannopoulos, V., Brunelle, F., Fournet, J. C., Robert, J. J., Aigrain, Y., Bellanne-Chantelot, C., and de Lonlay, P. (2011) Congenital hyperinsulinism: Current trends in diagnosis and therapy, Orphanet J. Rare Dis. 6, 63. 47. Cartier, E. A., Conti, L. R., Vandenberg, C. A., and Shyng, S. L. (2001) Defective trafficking and function of K-ATP channels caused by a sulfonylurea receptor 1 mutation associated


Page 37 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

with persistent hyperinsulinemic hypoglycemia of infancy, Proc. Natl. Acad. Sci. U. S. A. 98, 2882-2887. 48. Partridge, C. J., Beech, D. J., and Sivaprasadarao, A. (2001) Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism, J. Biol. Chem. 276, 3594735952. 49. Huopio, H., Shyng, S. L., Otonkoski, T., and Nichols, C. G. (2002) K(ATP) channels and insulin secretion disorders, Am. J. Physiol. Endocrinol. Metab. 283, E207-216. 50. Taschenberger, G., Mougey, A., Shen, S., Lester, L. B., LaFranchi, S., and Shyng, S. L. (2002) Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of K-ATP channels, J. Biol. Chem. 277, 17139-17146. 51. Yan, F. F., Lin, C. W., Weisiger, E., Cartier, E. A., Taschenberger, G., and Shyng, S. L. (2004) Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor, J. Biol. Chem. 279, 11096-11105. 52. Yan, F.-F., Lin, Y.-W., MacMullen, C., Ganguly, A., Stanley, C. A., and Shyng, S.-L. (2007) Congenital hyperinsulinism-associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels - identification and rescue, Diabetes 56, 2339-2348. 53. Saint-Martin, C., Zhou, Q., Martin, G. M., Vaury, C., Leroy, G., Arnoux, J. B., de Lonlay, P., Shyng, S. L., and Bellanne-Chantelot, C. (2015) Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism, Clin. Genet. 87, 448-454. 54. Pettit, R. S., and Fellner, C. (2014) CFTR modulators for the treatment of cystic fibrosis, Pharmacol. Therapeut. 39, 500-511. 55. Tummler, B. (2016) Treatment of cystic fibrosis with cftr modulators, Pneumologie 70, 301313. 56. Li, N., Wu, J. X., Ding, D., Cheng, J., Gao, N., and Chen, L. (2017) Structure of a pancreatic ATP-sensitive potassium channel, Cell 168, 101-110 e110. 57. Martin, G. M., Yoshioka, C., Rex, E. A., Fay, J. F., Xie, Q., Whorton, M. R., Chen, J. Z., and Shyng, S. L. (2017) Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating, Elife 6, e24149. 58. Martin, G. M., Rex, E. A., Devaraneni, P., Denton, J. S., Boodhansingh, K. E., DeLeon, D. D., Stanley, C. A., and Shyng, S. L. (2016) Pharmacological correction of trafficking defects in ATP-sensitive potassium channels caused by sulfonylurea receptor 1 mutations, J. Biol. Chem. 291, 21971-21983. 37 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 38 of 45

59. Mossessova, E., and Lima, C. D. (2000) Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast, Mol. Cell 5, 865-876. 60. Lewis, H. A., Buchanan, S. G., Burley, S. K., Conners, K., Dickey, M., Dorwart, M., Fowler, R., Gao, X., Guggino, W. B., Hendrickson, W. A., Hunt, J. F., Kearins, M. C., Lorimer, D., Maloney, P. C., Post, K. W., Rajashankar, K. R., Rutter, M. E., Sauder, J. M., Shriver, S., Thibodeau, P. H., Thomas, P. J., Zhang, M., Zhao, X., and Emtage, S. (2004) Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator, EMBO J. 23, 282-293. 61. de Araujo, E. D., Ikeda, L. K., Tzvetkova, S., and Kanelis, V. (2011) The first nucleotide binding domain of the sulfonylurea receptor 2a contains regulatory elements and is folded and functions as an independent module, Biochemistry 50, 6655-6666. 62. de Araujo, E. D., Alvarez, C. P., Lopez-Alonso, J. P., Sooklal, C. R., Stagljar, M., and Kanelis, V. (2015) Phosphorylation-dependent changes in nucleotide binding, conformation, and dynamics of the first nucleotide binding domain (NBD1) of the sulphonylurea receptor 2B (SUR2B), J. Biol. Chem. 290, 22699-22714 63. de Araujo, E. D., and Kanelis, V. (2014) Successful development and use of a thermodynamic stability screen for optimizing the yield of nucleotide binding domains, Protein Expr. Purif. 103, 38-47. 64. Pervushin, K., Riek, R., Wider, G., and Wuthrich, K. (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution, Proc. Natl. Acad. Sci. U. S. A. 94, 12366-12371. 65. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR 6, 277-293. 66. Johnson, B. A., and Blevins, R. A. (1994) NMRView: A computer program for the visualization and analysis of NMR data., J. Biomol. NMR 4, 603-614. 67. Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E., Markley, J. L., and Sykes, B. D. (1995) 1H, 13C and 15N chemical shift referencing in biomolecular NMR, J Biomol NMR 6, 135-140. 68. Hudson, R. P., Chong, P. A., Prostasevich, I. I., Vernon, R., Noy, E., Bihler, H., An, J. L., Kaild, O., Sela-Culang, I., Mense, M., Senderowitz, H., Brouillette, C. G., and FormanKay, J. D. (2012) Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of CFTR, J. Biol. Chem. 287, 28480-28494.


Page 39 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

69. Farrow, N. A., Muhandiram, R., Singer, A. U., Pascal, S. M., Kay, C. M., Gish, G., Shoelson, S. E., Pawson, T., Forman-Kay, J. D., and Kay, L. E. (1994) Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation, Biochemistry 33, 5984-6003. 70. Korzhnev, D. M., Skrynnikov, N. R., Millet, O., Torchia, D. A., and Kay, L. E. (2002) An nmr experiment for the accurate measurement of heteronuclear spin-lock relaxation rates, J. Am. Chem. Soc. 124, 10743-10753. 71. Finerty, P. J., Jr., Mittermaier, A. K., Muhandiram, R., Kay, L. E., and Forman-Kay, J. D. (2005) NMR dynamics-derived insights into the binding properties of a peptide interacting with an SH2 domain, Biochemistry 44, 694-703. 72. Kanelis, V., Forman-Kay, J. D., and Kay, L. E. (2001) Multidimensional NMR methods for protein structure determination, IUBMB Life 52, 291-302. 73. Sattler, M., Schleucher, J., and Griesinger, C. (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gardients, Prog. NMR. Spect. 34, 93-158. 74. Kanelis, V., Hudson, R. P., Thibodeau, P. H., Thomas, P. J., and Forman-Kay, J. D. (2010) NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR, EMBO J. 29, 263-277. 75. Smith, S. P., and Shaw, G. S. (1997) Assignment and secondary structure of calcium-bound human S100b, J. Biomol. NMR 10, 77-88. 76. Atreya, H. S. (2012) Isotope labelling in biomolecular NMR Springer-Verlag, Inc., New York. 77. Krishnarjuna, B., Jaipuria, G., Thakur, A., D'Silva, P., and Atreya, H. S. (2011) Amino acid selective unlabeling for sequence specific resonance assignments in proteins, J. Biomol. NMR 49, 39-51. 78. Liu, R., and Sharom, F. J. (1997) Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter, Biochemistry 36, 2836-2843. 79. Lakowicz, J. R., (Ed.) (2006) Principles of fluorescence spectroscopy, 3rd edition, 3 ed., Springer: New York. 80. Schlamadinger, D. E., Kats, D. I., and Kim, J. E. (2010) Quenching of tryptophan fluorescence in unfolded cytochrome c: A biophysics experiment for physical chemistry students, J. Chem. Educ. 87, 961-964.


Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 40 of 45

81. Lehrer, S. S. (1971) Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion, Biochemistry 10, 3254-3263. 82. Nikolaeva, O., Moiseyev, G., Rodgers, K. K., and Ma, J. X. (2011) Binding to lipid membrane induces conformational changes in RPE65: Implications for its isomerohydrolase activity, Biochem. J. 436, 591-597. 83. Viguera, A. R., Arrondo, J. L., Musacchio, A., Saraste, M., and Serrano, L. (1994) Characterization of the interaction of natural proline-rich peptides with five different SH3 domains, Biochemistry 33, 10925-10933. 84. Niranjan, Y., Ungureanu, D., Hammaren, H., Sanz-Sanz, A., Westphal, A. H., Borst, J. W., Silvennoinen, O., and Hilhorst, R. (2013) Analysis of steady-state Förster resonance energy transfer data by avoiding pitfalls: Interaction of JAK2 tyrosine kinase with Nmethylanthraniloyl nucleotides, Anal. Biochem. 442, 213-222. 85. Kubala, M., Plasek, J., and Amler, E. (2003) Limitations in linearized analyses of binding equilibria: Binding of TNP-ATP to the H-4-H-5 loop of Na/K-ATPase, Eur. Biophys. J. Biophy. 32, 363-369. 86. Sanchez-Puig, N., Veprintsev, D. B., and Fersht, A. R. (2005) Human full-length securin is a natively unfolded protein, Protein Sci. 14, 1410-1418. 87. Li, X., Romero, P., Rani, M., Dunker, A. K., and Obradovic, Z. (1999) Predicting protein disorder for N-, C-, and internal regions, Genome Inform. Ser. 10, 30-40. 88. Romero, Obradovic, and Dunker, K. (1997) Sequence data analysis for long disordered regions prediction in the calcineurin family, Genome Inform. Ser. 8, 110-124. 89. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., and Dunker, A. K. (2001) Sequence complexity of disordered protein, Proteins 42, 38-48. 90. Marsh, J. A., Singh, V. K., Jia, Z., and Forman-Kay, J. D. (2006) Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: Implications for fibrillation, Protein Sci. 15, 2795-2804. 91. ter Beek, J., Guskov, A., and Slotboom, D. J. (2014) Structural diversity of ABC transporters, J. Gen. Physiol. 143, 419-435. 92. Bukowska, M. A., Hohl, M., Geertsma, E. R., Hurlimann, L. M., Grutter, M. G., and Seeger, M. A. (2015) A transporter motor taken apart: Flexibility in the nucleotide binding domains of a heterodimeric ABC exporter, Biochemistry 54, 3086-3099.


Page 41 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

93. Farrow, N. A., Zhang, O., Forman-Kay, J. D., and Kay, L. E. (1995) Comparison of the backbone dynamics of a folded and an unfolded SH3 domain existing in equilibrium in aqueous buffer, Biochemistry 34, 868-878. 94. López-Alonso, J. P., de Araujo, E. D., and Kanelis, V. (2012) NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A, Biochemistry 51, 92119222. 95. Gekko, K., and Timasheff, S. N. (1981) Thermodynamic and kinetic examination of protein stabilization by glycerol, Biochemistry 20, 4677-4686. 96. Graslund, S., Nordlund, P., Weigelt, J., Hallberg, B. M., Bray, J., Gileadi, O., Knapp, S., Oppermann, U., Arrowsmith, C., Hui, R., Ming, J., dhe-Paganon, S., Park, H. W., Savchenko, A., Yee, A., Edwards, A., Vincentelli, R., Cambillau, C., Kim, R., Kim, S. H., Rao, Z., Shi, Y., Terwilliger, T. C., Kim, C. Y., Hung, L. W., Waldo, G. S., Peleg, Y., Albeck, S., Unger, T., Dym, O., Prilusky, J., Sussman, J. L., Stevens, R. C., Lesley, S. A., Wilson, I. A., Joachimiak, A., Collart, F., Dementieva, I., Donnelly, M. I., Eschenfeldt, W. H., Kim, Y., Stols, L., Wu, R., Zhou, M., Burley, S. K., Emtage, J. S., Sauder, J. M., Thompson, D., Bain, K., Luz, J., Gheyi, T., Zhang, F., Atwell, S., Almo, S. C., Bonanno, J. B., Fiser, A., Swaminathan, S., Studier, F. W., Chance, M. R., Sali, A., Acton, T. B., Xiao, R., Zhao, L., Ma, L. C., Hunt, J. F., Tong, L., Cunningham, K., Inouye, M., Anderson, S., Janjua, H., Shastry, R., Ho, C. K., Wang, D., Wang, H., Jiang, M., Montelione, G. T., Stuart, D. I., Owens, R. J., Daenke, S., Schutz, A., Heinemann, U., Yokoyama, S., Bussow, K., and Gunsalus, K. C. (2008) Protein production and purification, Nat. Methods 5, 135-146. 97. Kumar, R. (2009) Role of naturally occurring osmolytes in protein folding and stability, Arch. Biochem. Biophys. 491, 1-6. 98. Sousa, R. (1995) Use of glycerol, polyols and other protein structure stabilizing agents in protein crystallization, Acta Crystallogr. D. Biol. Crystallogr. 51, 271-277. 99. Proks, P. (2013) Neonatal diabetes caused by activating mutations in the sulphonylurea receptor, Diabetes Metab. J. 37, 157-164. 100. Pain, R. H. (2005) Determining the fluorescence spectrum of a protein, Curr. Protoc. Protein Sci. Chapter 7, Unit 7 7. 101. Russell, P. L., and Sharom, F. J. (2006) Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter, Biochem. J. 399, 315323. 102. Kubala, M., Grycova, L., Lansky, Z., Sklenovsky, P., Janovska, M., Otyepka, M., and Teisinger, J. (2009) Changes in electrostatic surface potential of Na+/K+-ATPase cytoplasmic headpiece induced by cytoplasmic ligand(s) binding, Biophys. J. 97, 17561764. 41 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 42 of 45

103. Thibodeau, P. H., Brautigam, C. A., Machius, M., and Thomas, P. J. (2005) Side chain and backbone contributions of Phe508 to CFTR folding, Nat. Struct. Mol. Biol. 12, 10-16. 104. Cheng, J. Q., Jiang, W., and Hackney, D. D. (1998) Interaction of MANT-adenosine nucleotides and magnesium with kinesin, Biochemistry 37, 5288-5295. 105. Dayan, G., Jault, J. M., Baubichon-Cortay, H., Baggetto, L. G., Renoir, J. M., Baulieu, E. E., Gros, P., and DiPietro, A. (1997) Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site, Biochemistry 36, 15208-15215. 106. Divita, G., Dipietro, A., Roux, B., and Gautheron, D. C. (1992) Differential nucleotide binding to catalytic and noncatalytic sites and related conformational-changes involving alpha/beta-subunit interactions as monitored by sensitive intrinsic fluorescence in Schizosaccharomyces pombe mitochondrial-F1, Biochemistry 31, 5791-5798. 107. Divita, G., Goody, R. S., Gautheron, D. C., and Dipietro, A. (1993) Structural mapping of catalytic site with respect to alpha-subunit and noncatalytic site in yeast mitochondrial F1-ATPase using fluorescence resonance energy transfer, J. Biol. Chem. 268, 1317813186. 108. Rabeh, W. M., Bossard, F., Xu, H., Okiyoneda, T., Bagdany, M., Mulvihill, C. M., Du, K., di Bernardo, S., Liu, Y., Konermann, L., Roldan, A., and Lukacs, G. L. (2012) Correction of both NBD1 energetics and domain interface is required to restore DeltaF508 CFTR folding and function, Cell 148, 150-163. 109. Ortiz, D., and Bryan, J. (2015) Neonatal diabetes and congenital hyperinsulinism caused by mutations in ABCC8/SUR1 are associated with altered and opposite affinities for ATP and ADP, Front. Endocrinol. (Lausanne) 6, 48. 110. Richardson, J. S. (1981) The anatomy and taxonomy of protein structure, Adv. Protein Chem. 34, 167-339. 111. de Wet, H., Mikhailov, M. V., Fotinou, C., Dreger, M., Craig, T. J., Venien-Bryan, C., and Ashcroft, F. M. (2007) Studies of the ATPase activity of the ABC protein SUR1, FEBS J. 274, 3532-3544. 112. Hung, L. W., Wang, I. X., Nikaido, K., Liu, P. Q., Ames, G. F., and Kim, S. H. (1998) Crystal structure of the ATP-binding subunit of an ABC transporter, Nature 396, 703707. 113. Smith, P. C., Karpowich, N., Millen, L., Moody, J. E., Rosen, J., Thomas, P. J., and Hunt, J. F. (2002) ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer, Mol. Cell 10, 139-149.


Page 43 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

114. Verdon, G., Albers, S. V., Dijkstra, B. W., Driessen, A. J., and Thunnissen, A. M. (2003) Crystal structures of the ATPase subunit of the glucose ABC transporter from Sulfolobus solfataricus: Nucleotide-free and nucleotide-bound conformations, J. Mol. Biol. 330, 343358. 115. Zaitseva, J., Jenewein, S., Jumpertz, T., Holland, I. B., and Schmitt, L. (2005) H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB, EMBO J. 24, 1901-1910. 116. Nestorowicz, A., Glaser, B., Wilson, B. A., Shyng, S. L., Nichols, C. G., Stanley, C. A., Thornton, P. S., and Permutt, M. A. (1998) Genetic heterogeneity in familial hyperinsulinism, Hum. Mol. Genet. 7, 1119-1128. 117. Shyng, S. L., Ferrigni, T., Shepard, J. B., Nestorowicz, A., Glaser, B., Permutt, M. A., and Nichols, C. G. (1998) Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy, Diabetes 47, 1145-1151. 118. Gribble, F. M., Tucker, S. J., and Ashcroft, F. M. (1997) The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide, EMBO J. 16, 1145-1152. 119. Suchi, M., MacMullen, C. M., Thornton, P. S., Adzick, N. S., Ganguly, A., Ruchelli, E. D., and Stanley, C. A. (2006) Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism, Mod. Pathol. 19, 122-129. 120. Ohkubo, K., Nagashima, M., Naito, Y., Taguchi, T., Suita, S., Okamoto, N., Fujinaga, H., Tsumura, K., Kikuchi, K., and Ono, J. (2005) Genotypes of the pancreatic beta-cell KATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy, Clin. Endocrinol. (Oxf). 62, 458-465. 121. de Wet, H., Proks, P., Lafond, M., Aittoniemi, J., Sansom, M. S., Flanagan, S. E., Pearson, E. R., Hattersley, A. T., and Ashcroft, F. M. (2008) A mutation (R826W) in nucleotidebinding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes, EMBO Rep. 9, 648-654. 122. Ramaen, O., Leulliot, N., Sizun, C., Ulryck, N., Pamlard, O., Lallemand, J. Y., Tilbeurgh, H., and Jacquet, E. (2006) Structure of the human multidrug resistance protein 1 nucleotide binding domain 1 bound to Mg2+/ATP reveals a non-productive catalytic site, J. Mol. Biol. 359, 940-949. 123. Lewis, H. A., Zhao, X., Wang, C., Sauder, J. M., Rooney, I., Noland, B. W., Lorimer, D., Kearins, M. C., Conners, K., Condon, B., Maloney, P. C., Guggino, W. B., Hunt, J. F., and Emtage, S. (2005) Impact of the deltaf508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure, J. Biol. Chem. 280, 1346-1353. 43 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 44 of 45

124. Tornovsky, S., Crane, A., Cosgrove, K. E., Hussain, K., Lavie, J., Heyman, M., Nesher, Y., Kuchinski, N., Ben-Shushan, E., Shatz, O., Nahari, E., Potikha, T., Zangen, D., Tenenbaum-Rakover, Y., De Vries, L., Argente, J., Gracia, R., Landau, H., Eliakim, A., Lindley, K., Dunne, M. J., Aguilar-Bryan, L., and Glaser, B. (2004) Hyperinsulinism of infancy: Novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity, J. Clin. Endocr. Metab. 89, 6224-6234. 125. Meissner, T., Beinbrech, B., and Mayatepek, E. (1999) Congenital hyperinsulinism: Molecular basis of a heterogeneous disease, Hum. Mutat. 13, 351-361. 126. de Lonlay-Debeney, P., Poggi-Travert, F., Fournet, J. C., Sempoux, C., Dionisi Vici, C., Brunelle, F., Touati, G., Rahier, J., Junien, C., Nihoul-Fekete, C., Robert, J. J., and Saudubray, J. M. (1999) Clinical features of 52 neonates with hyperinsulinism, N. Engl. J. Med. 340, 1169-1175.


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

NBD1-WT NBD1-K890T 110

115 15N (ppm)

Page 45 of 45

120

125 W928’

130

W778’

10.0

9.0 1H (ppm)

8.0

7.0

Graphic for Table of Contents Alvarez et al.

ACS Paragon Plus Environment

Hyperinsulinism-Causing Mutations Cause Multiple Molecular Defects

Recommend Documents